PAHC Phibro Animal Health Corporation
Stock · NasdaqGM · United States · Healthcare · US71742Q1067
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Phibro Animal Health Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
32.96 USD
-6.89%
52-week range
28.25 – 60.08
Dividend yield1.46%
Market cap1.3B
NowoTrade score
42 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:54. Information, not advice.
Results
Next results
03 Feb 2027
in 87 days · 16:00 · estimate 0.94
Last results
0.79 vs 0.78 estimated
04 Nov 2026 · In line +0.9%
Beat the estimate
11 of 12
0 missed · 1 in line
Average surprise
+17.9%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 03 Feb 2027 16:00 | 0.94 | — | — | Upcoming |
| 04 Nov 2026 16:00 | 0.78 | 0.79 | +0.9% | In line |
| 26 Aug 2026 16:00 | 0.73 | 0.85 | +17.1% | Beat |
| 06 May 2026 16:00 | 0.71 | 0.76 | +6.5% | Beat |
| 04 Feb 2026 16:00 | 0.67 | 0.87 | +29.9% | Beat |
| 05 Nov 2025 16:00 | 0.60 | 0.73 | +21.1% | Beat |
| 27 Aug 2025 17:00 | 0.52 | 0.57 | +9.4% | Beat |
| 07 May 2025 16:00 | 0.52 | 0.63 | +21.2% | Beat |
| 05 Feb 2025 16:00 | 0.45 | 0.54 | +19.2% | Beat |
| 06 Nov 2024 16:00 | 0.25 | 0.35 | +41.4% | Beat |
| 28 Aug 2024 16:00 | 0.33 | 0.41 | +23.1% | Beat |
| 08 May 2024 16:00 | 0.29 | 0.31 | +6.7% | Beat |
| 07 Feb 2024 16:00 | 0.28 | 0.33 | +18.0% | Beat |
| 08 Nov 2023 16:00 | 0.23 | 0.14 | -39.4% | Miss |
| 30 Aug 2023 16:00 | 0.38 | 0.38 | -1.1% | Miss |
| 03 May 2023 16:00 | 0.34 | 0.29 | -15.3% | Miss |
| 08 Feb 2023 16:00 | 0.30 | 0.34 | +12.2% | Beat |
| 09 Nov 2022 16:00 | 0.27 | 0.21 | -20.9% | Miss |
| 24 Aug 2022 16:00 | 0.38 | 0.36 | -5.9% | Miss |
| 04 May 2022 16:00 | 0.35 | 0.33 | -6.6% | Miss |
| 09 Feb 2022 16:00 | 0.33 | 0.37 | +12.9% | Beat |
| 02 Nov 2021 16:00 | 0.29 | 0.25 | -14.8% | Miss |
| 25 Aug 2021 16:00 | 0.31 | 0.32 | +2.4% | Beat |
| 06 May 2021 16:00 | 0.32 | 0.34 | +5.4% | Beat |
| 03 Feb 2021 16:00 | 0.28 | 0.34 | +22.5% | Beat |
| 04 Nov 2020 16:00 | 0.23 | 0.27 | +15.4% | Beat |
| 26 Aug 2020 16:00 | 0.22 | 0.17 | -22.5% | Miss |
| 07 May 2020 17:00 | 0.34 | 0.38 | +11.8% | Beat |
| 03 Feb 2020 16:00 | 0.29 | 0.34 | +18.9% | Beat |
| 04 Nov 2019 16:00 | 0.24 | 0.19 | -21.5% | Miss |
| 27 Aug 2019 16:00 | 0.36 | 0.33 | -8.8% | Miss |
| 06 May 2019 16:00 | 0.43 | 0.39 | -9.5% | Miss |
| 06 Feb 2019 16:00 | 0.43 | 0.41 | -4.7% | Miss |
| 06 Nov 2018 16:00 | 0.41 | 0.39 | -4.1% | Miss |
| 27 Aug 2018 16:00 | 0.42 | 0.55 | +30.1% | Beat |
| 07 May 2018 16:00 | 0.44 | 0.48 | +8.8% | Beat |
| 05 Feb 2018 16:00 | 0.39 | 0.35 | -10.0% | Miss |
| 06 Nov 2017 16:00 | 0.37 | 0.38 | +2.2% | Beat |
| 30 Aug 2017 16:00 | 0.34 | 0.39 | +14.0% | Beat |
| 08 May 2017 16:00 | 0.34 | 0.42 | +23.9% | Beat |
| 06 Feb 2017 16:00 | 0.35 | 0.34 | -4.0% | Miss |
| 09 Nov 2016 16:00 | 0.36 | 0.36 | -0.7% | In line |
| 29 Aug 2016 16:00 | 0.37 | 0.40 | +7.3% | Beat |
| 09 May 2016 16:00 | 0.41 | 0.38 | -8.1% | Miss |
| 09 Feb 2016 16:00 | 0.40 | 0.39 | -3.3% | Miss |
| 09 Nov 2015 16:00 | 0.41 | 0.44 | +6.8% | Beat |
| 09 Sep 2015 17:00 | 0.38 | 0.44 | +14.4% | Beat |
| 11 May 2015 16:00 | 0.36 | 0.41 | +15.3% | Beat |
| 10 Feb 2015 16:00 | 0.35 | 0.35 | +0.2% | In line |
| 11 Nov 2014 16:00 | 0.35 | 0.51 | +45.8% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 1.5B | +17.1% | 99.7M | 6.6% | 2.43 | +104.2% | 9.9M |
| 2025 | 1.3B | +27.4% | 48.3M | 3.7% | 1.19 | +1,883.3% | 41.8M |
| 2024 | 1B | +4.1% | 2.4M | 0.2% | 0.06 | -92.6% | 46.4M |
| 2023 | 977.9M | — | 32.6M | 3.3% | 0.81 | — | -38.5M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Oct 2024 | 22.46 | 25.11 | 20.86 | 23.12 | +2.66% | 3,926,800 | |
| Sep 2024 | 20.73 | 22.84 | 19.37 | 22.52 | +7.24% | 4,233,500 | 0.1200 |
| Aug 2024 | 18.98 | 22.31 | 16.50 | 21.00 | +11.23% | 3,696,200 | |
| Jul 2024 | 16.77 | 19.55 | 16.28 | 18.88 | +12.58% | 2,799,500 | |
| Jun 2024 | 17.79 | 17.97 | 16.35 | 16.77 | -4.88% | 2,379,900 | 0.1200 |
| May 2024 | 16.77 | 18.70 | 16.06 | 17.63 | +5.57% | 2,986,600 | |
| Apr 2024 | 12.99 | 16.90 | 12.17 | 16.70 | +29.16% | 3,369,600 | |
| Mar 2024 | 13.02 | 13.92 | 11.99 | 12.93 | 0.00% | 3,019,200 | 0.1200 |
| Feb 2024 | 10.90 | 13.35 | 10.04 | 12.93 | +19.61% | 3,521,200 | |
| Jan 2024 | 11.47 | 12.05 | 10.77 | 10.81 | -6.65% | 2,710,900 | |
| Dec 2023 | 9.62 | 11.91 | 9.50 | 11.58 | +20.75% | 5,540,200 | |
| Nov 2023 | 10.97 | 12.42 | 9.40 | 9.59 | -12.18% | 4,269,800 | 0.1200 |
| Oct 2023 | 12.79 | 13.00 | 10.64 | 10.92 | -14.49% | 2,813,900 | |
| Sep 2023 | 13.90 | 14.51 | 12.13 | 12.77 | -8.46% | 2,734,500 | 0.1200 |
| Aug 2023 | 14.41 | 15.69 | 13.91 | 13.95 | -3.66% | 1,549,800 | |
| Jul 2023 | 13.70 | 15.16 | 13.53 | 14.48 | +5.69% | 1,446,500 | |
| Jun 2023 | 13.30 | 14.23 | 12.89 | 13.70 | +3.01% | 2,395,500 | 0.1200 |
| May 2023 | 15.59 | 15.96 | 12.65 | 13.30 | -14.52% | 1,742,100 | |
| Apr 2023 | 15.36 | 15.98 | 14.52 | 15.56 | +1.57% | 1,490,500 | |
| Mar 2023 | 15.73 | 16.52 | 14.35 | 15.32 | -2.48% | 2,716,200 | |
| Feb 2023 | 15.39 | 16.43 | 15.38 | 15.71 | +2.01% | 2,334,600 | 0.1200 |
| Jan 2023 | 13.44 | 15.69 | 13.41 | 15.40 | +14.84% | 2,150,800 | |
| Dec 2022 | 12.32 | 13.92 | 12.14 | 13.41 | +8.94% | 3,929,300 | |
| Nov 2022 | 14.85 | 15.18 | 11.75 | 12.31 | -16.20% | 3,644,300 | 0.1200 |
| Oct 2022 | 13.32 | 14.96 | 12.65 | 14.69 | +10.53% | 3,556,200 |
Page 2 of 3
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Phibro Animal Health (PAHC) After Guidance Hold Looks Undervalued On The Leading Narrative (opens in a new tab) Simply Wall St. · 08 Nov 2026 08:08
- Phibro Animal Health (PAHC) Stock May Be Below Fair Value Following Revenue Beat (opens in a new tab) Simply Wall St. · 08 Nov 2026 07:08
- Phibro Animal (PAHC) Q1 2027 Earnings Call Transcript (opens in a new tab) Motley Fool · 07 Nov 2026 17:32
- Phibro Animal Health Corp (PAHC) (Q1 2027) Earnings Call Highlights: Solid Start to Fiscal 2027 ... (opens in a new tab) GuruFocus.com · 07 Nov 2026 01:11
- Phibro Animal Health Corporation 2027 Q1 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 07 Nov 2026 00:26
- Phibro Animal Health Corporation (PAHC) Q1 2027 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 07 Nov 2026 00:24
- What Phibro Animal Health (PAHC) Said on Its Q1 Earnings Call (opens in a new tab) MarketBeat · 05 Nov 2026 22:14
- Phibro Animal Health Q1 2027 Earnings Call Transcript (opens in a new tab) Benzinga · 05 Nov 2026 10:28
- Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 05 Nov 2026 00:30
- Phibro: Fiscal Q1 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 21:52
- Phibro Animal Health (NASDAQ:PAHC) exceeds Q3 CY2026 expectations (opens in a new tab) StockStory · 04 Nov 2026 21:34
- Phibro Animal Health Corporation Reports First Quarter Results, Maintains Financial Guidance (opens in a new tab) 04 Nov 2026 21:22
- Phibro Animal Health Affirms FY2027 GAAP EPS Guidance of $2.98-$3.22 (opens in a new tab) Benzinga · 04 Nov 2026 17:43
- Phibro Animal Health Affirms FY2027 Adj EPS Guidance of $3.41-$3.59 vs $3.50 Est; Affirms FY2027 Sales Guidance of $1.550B-$1.600B vs $1.578B Est (opens in a new tab) Benzinga · 04 Nov 2026 17:42
- Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy? (opens in a new tab) Zacks · 28 Oct 2026 13:00
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 35.40 USD
- Market cap
- 1.3B
- Dividend yield
- 1.46%
- 5-year average yield
- 2.06%
- Payout ratio
- 19%
- Last dividend
- 0.1200 USD · 25 Nov 2026
- Next ex-dividend date
- 25 Nov 2026
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 02 Sep 2026 | 0.1200 USD |
| 03 Jun 2026 | 0.1200 USD |
| 04 Mar 2026 | 0.1200 USD |
| 26 Nov 2025 | 0.1200 USD |
| 03 Sep 2025 | 0.1200 USD |
| 04 Jun 2025 | 0.1200 USD |
| 05 Mar 2025 | 0.1200 USD |
| 27 Nov 2024 | 0.1200 USD |
| 04 Sep 2024 | 0.1200 USD |
| 05 Jun 2024 | 0.1200 USD |
| 05 Mar 2024 | 0.1200 USD |
| 28 Nov 2023 | 0.1200 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 6.1 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 17.9 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 1.7 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 10.3 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 5.0 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 5.0 / 5 |
|
- Total debt has risen three years in a row
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A). Warnings take 6 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 13.13× | Good | 30.65× |
| P/E (forward) | 8.56× | Good | 14.89× |
| Price / book | 3.2× | Weak | 3.81× |
| Price / sales | 0.87× | Good | 3.19× |
| EV / EBITDA | 8.3× | Good | 12.63× |
| Free cash flow yield | -0.4% | Weak | 2.5% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 33.3% | Fair | 58.6% |
| Operating margin | 13% | Fair | 7.8% |
| Net margin | 6.7% | Fair | 2.8% |
| Return on equity | 28.2% | Good | 5.7% |
| Return on assets | 8.4% | Good | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 15.8% | Good | 10.8% |
| EPS growth / year | 44.2% | Good | 9.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 1.9× | Weak | 0.48× |
| Net debt / EBITDA | 2.87× | Fair | 1.6× |
| Interest cover | 4.41× | Fair | 2.69× |
| Current ratio | 3.2× | Good | 2.39× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 19.1% | Good | 0% |
| Payout of free cash flow (3 years) | 59.5% | Fair | — |
| Dividend growth / year | 1.8% | Weak | 7.1% |
| Years of rising dividends | 0 | Weak | 2 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow PAHC and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.